Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Withdrawn
Company Name
Vyrix Pharmaceuticals, Inc.
Proposed Ticker
VYRX
CUSIP
N/A
Business Description
A specialty biopharmaceutical company focused on developing and commercializing late-stage prescription drug products to improve men’s health, and quality of life.
Lead Underwriter
Aegis Capital Corp, Fordham Financial Management, Inc.
Co-Managers
N/A
Initial Shares
N/A
Revised Initial Shares
N/A
Initial Price
N/A
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.
